FdaApplication
NDA 021365
Identifiers
- fda_app_no: NDA021365
Properties
| Property | Value |
|---|---|
| applicant_name | ABBVIE INC |
| application_type | NDA |
| approval_date | 2002-11-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEXAPRO | ESCITALOPRAM OXALATE | EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product